Provider profile
Deepbridge Capital
UK EIS manager · 2 offers on WiT Money
2
Products covered
Enterprise Investment Scheme
Overview
About Deepbridge Capital
Editorial summary — not an endorsement.
Deepbridge Capital is listed on WiT Money as the manager of 2 Enterprise Investment Scheme offers. Deepbridge Technology Growth EIS (Technology): Open; Deepbridge Life Sciences EIS (Healthcare): Open. EIS investments are high risk. You could lose all of your money, and shares are usually illiquid. Target returns and deployment periods are targets, not guarantees. The dataset records 30% income tax relief on qualifying EIS subscriptions, with a minimum holding period of 3 years. Relief depends on your circumstances and current rules, is not automatic, and can be withdrawn. Tax relief does not reduce investment risk. Details last verified 2026-08-09.
FCA authorisation for Deepbridge Capital is not recorded in the WiT Money EIS dataset. Last checked in the WiT Money dataset on 2026-08-09. Confirm current permissions on the Financial Services Register before you invest.
Products offered
What Deepbridge Capital offers
Key product areas we track on WiT Money — rates and availability change.
Enterprise Investment Scheme
Deepbridge Technology Growth EIS
Deepbridge Technology Growth EIS: EIS fund. Technology. High-growth technology companies with proven technology and IP. Target deployment Not verified. Target return Not verified, not guaranteed. Next deadline Open offer. Illiquid / no ready market. Current charges are not verified in the WiT Money dataset. EISA lists this as an open offer. Verify all commercial terms against current provider documents. Capital is at risk.
Open · Not verified target, not guaranteed · Technology
Compare in categoryEnterprise Investment Scheme
Deepbridge Life Sciences EIS
Deepbridge Life Sciences EIS: EIS fund. Healthcare. Biopharma, biotechnology and medical technology. Target deployment Not verified. Target return Not verified, not guaranteed. Next deadline Open offer. Illiquid / no ready market. Current charges are not verified in the WiT Money dataset. Specialist life-sciences EIS; current open-offer status supported by EISA. Capital is at risk.
Open · Not verified target, not guaranteed · Healthcare
Compare in categoryAt a glance
Pros and cons
Recorded product facts for Deepbridge Capital. Terms, eligibility and pricing can change.
Pros
- Deepbridge Technology Growth EIS — target Not verified, not guaranteed
- Deepbridge Life Sciences EIS — target Not verified, not guaranteed
- EIS fund
- Technology focus
- Healthcare focus
Cons
- High risk — you could lose all of your money
- Illiquid — there is usually no ready market for EIS shares
- Target returns are not guaranteed
- Current charges should be checked in provider documents
Compare
Comparison links
See how Deepbridge Capital stacks up against other UK providers.
Compare EIS investments
See Deepbridge Capital alongside other UK EIS funds and managed portfolios.
Open comparisonFAQ
Frequently asked questions about Deepbridge Capital
Ready to compare Deepbridge Capital?
Jump into a live comparison table and shortlist products that match your needs.